Screening for osteoporosis in patients with inflammatory bowel disease by using urinary N-telopeptides

Abstract

Our data suggest that N-telopeptide levels could be used as a tool for the screening of osteoporosis and for selecting those inflammatory bowel disease patients where bone mineral density measurement is indicated.